Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 2
2007 1
2008 2
2009 1
2010 2
2013 1
2014 2
2016 4
2017 5
2018 6
2019 3
2020 8
2021 4
2022 1
2023 3
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Results by year

Filters applied: . Clear all
Page 1
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis.
Harrison SA, Bedossa P, Guy CD, Schattenberg JM, Loomba R, Taub R, Labriola D, Moussa SE, Neff GW, Rinella ME, Anstee QM, Abdelmalek MF, Younossi Z, Baum SJ, Francque S, Charlton MR, Newsome PN, Lanthier N, Schiefke I, Mangia A, Pericàs JM, Patil R, Sanyal AJ, Noureddin M, Bansal MB, Alkhouri N, Castera L, Rudraraju M, Ratziu V; MAESTRO-NASH Investigators. Harrison SA, et al. N Engl J Med. 2024 Feb 8;390(6):497-509. doi: 10.1056/NEJMoa2309000. N Engl J Med. 2024. PMID: 38324483 Clinical Trial.
Budesonide as first-line treatment in patients with autoimmune hepatitis seems inferior to standard predniso(lo)ne administration.
Díaz-González Á, Hernández-Guerra M, Pérez-Medrano I, Sapena V, Riveiro-Barciela M, Barreira-Díaz A, Gómez E, Morillas RM, Del Barrio M, Escudé L, Mateos B, Horta D, Gómez J, Conde I, Ferre-Aracil C, El Hajra I, Arencibía A, Zamora J, Fernández A, Salcedo M, Molina E, Soria A, Estévez P, López C, Álvarez-Navascúes C, García-Retortillo M, Crespo J, Londoño MC; ColHai Registry. Díaz-González Á, et al. Among authors: conde i. Hepatology. 2023 Apr 1;77(4):1095-1105. doi: 10.1097/HEP.0000000000000018. Epub 2023 Jan 3. Hepatology. 2023. PMID: 36626622 Free article.
Hepatitis C-related cirrhosis. Current status.
Conde I, Vinaixa C, Berenguer M. Conde I, et al. Med Clin (Barc). 2017 Jan 20;148(2):78-85. doi: 10.1016/j.medcli.2016.09.019. Epub 2016 Nov 14. Med Clin (Barc). 2017. PMID: 27855947 Review. English, Spanish.
Clinical presentation, causative drugs and outcome of patients with autoimmune features in two prospective DILI registries.
García-Cortés M, Ortega-Alonso A, Matilla-Cabello G, Medina-Cáliz I, Castiella A, Conde I, Bonilla-Toyos E, Pinazo-Bandera J, Hernández N, Tagle M, Nunes V, Parana R, Bessone F, Kaplowitz N, Lucena MI, Alvarez-Alvarez I, Robles-Díaz M, Andrade RJ. García-Cortés M, et al. Among authors: conde i. Liver Int. 2023 Aug;43(8):1749-1760. doi: 10.1111/liv.15623. Epub 2023 Jun 3. Liver Int. 2023. PMID: 37269163
Ertapenem neurotoxicity in liver transplantation.
Martínez Delgado S, Mínguez Sabater A, Ladrón Abia P, Aguilera Sancho-Tello MV, García Eliz M, Conde I. Martínez Delgado S, et al. Among authors: conde i. Rev Esp Enferm Dig. 2022 Apr;114(4):240-241. doi: 10.17235/reed.2021.8469/2021. Rev Esp Enferm Dig. 2022. PMID: 34933565 Free article.
Competency of different cell models to predict human hepatotoxic drugs.
Gómez-Lechón MJ, Tolosa L, Conde I, Donato MT. Gómez-Lechón MJ, et al. Among authors: conde i. Expert Opin Drug Metab Toxicol. 2014 Nov;10(11):1553-68. doi: 10.1517/17425255.2014.967680. Epub 2014 Oct 9. Expert Opin Drug Metab Toxicol. 2014. PMID: 25297626 Review.
Characterization of drug-induced liver injury associated with drug reaction with eosinophilia and systemic symptoms in two prospective DILI registries.
Medina-Cáliz I, Sanabria-Cabrera J, Villanueva-Paz M, Aukštikalnė L, Stephens C, Robles-Díaz M, Pinazo-Bandera JM, García-Cortes M, Conde I, Soriano G, Bessone F, Hernandez N, Nunes V, Paraná R, Lucena MI, Andrade RJ, Niu H, Alvarez-Alvarez I. Medina-Cáliz I, et al. Among authors: conde i. Arch Toxicol. 2024 Jan;98(1):303-325. doi: 10.1007/s00204-023-03630-0. Epub 2023 Dec 5. Arch Toxicol. 2024. PMID: 38051367 Free PMC article.
Primary biliary cholangitis and SARS-CoV-2 infection: incidence, susceptibility and outcomes.
Ampuero J, Lucena A, Hernández-Guerra M, Moreno-Moraleda I, Arenas J, Conde I, Muñoz L, Canillas L, Fernandez E, Quiñones R, Simon MA, Gómez-Dominguez E, Gutierrez ML, Fernandez-Rodriguez C, Domper-Arnal MJ, Jorquera F, Garcia-Buey ML, Garcia-Retortillo M, Morillas R, Berenguer M, Casado M, Morales-Arraez D, Sousa JM, Molina E. Ampuero J, et al. Among authors: conde i. Gut. 2021 Dec 7:gutjnl-2021-325700. doi: 10.1136/gutjnl-2021-325700. Online ahead of print. Gut. 2021. PMID: 34876479 No abstract available.
42 results